Recent developments driving growth in this area make the advanced, AI-supported digitization of pharma pipelines inevitable.

Today there are more options than ever for managing migraine effectively. Find out what might work for you with this comprehensive guide to acute and preventive prescription drugs.

Doctors and scientists believe migraine is due to "the result of abnormal brain activity affecting nerve signals, chemicals ...

Migraine is a common neurological syndrome that affects approximately 10–20% of the population. The pathophysiology of migraine is unclear. 5-hydroxytriptamine is a key mediator in the ...

For migraine sufferers who need immediate relief without the ... move to build out Tonix's commercial infrastructure ahead of the FDA submission of its New Drug Application for TNX-102 SL, its ...

Tonix Pharmaceuticals (NASDAQ: TNXP) through its subsidiary Tonix Medicines, has introduced two fast-acting migraine treatments, Zembrace® SymTouch ...

In September 2024, the Company presented multiple data analyses at Sleep Europe 2024, including results from the SYMPHONY ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

Axsome Therapeutics' Q3 2024 earnings report shows a revenue beat with $104.8m. See why I think selling AXSM stock on any ...

Biohaven Ltd. (BHVN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Tyler ...

Covering Saudi Arabia’s markets, the report includes: It encompasses a robust vendor analysis tailored to assist clients in enhancing their market positioning. Specifically, the report furnishes a ...

Cash, cash equivalents, marketable securities and restricted cash as of October 2, 2024 totaled approximately $642 million Achieved positive topline trial results ...